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Abstract
Even in the absence of an adaptive immune system in murine models, lymphatic dilatation and dysfunction occur in filarial
infections, although severe irreversible lymphedema and elephantiasis appears to require an intact adaptive immune
response in human infections. To address how filarial parasites and their antigens influence the lymphatics directly, human
lymphatic endothelial cells were exposed to filarial antigens, live parasites, or infected patient serum. Live filarial parasites or
filarial antigens induced both significant LEC proliferation and differentiation into tube-like structures in vitro. Moreover,
serum from patently infected (microfilaria positive) patients and those with longstanding chronic lymphatic obstruction
induced significantly increased LEC proliferation compared to sera from uninfected individuals. Differentiation of LEC into
tube-like networks was found to be associated with significantly increased levels of matrix metalloproteases and inhibition
of their TIMP inhibitors (Tissue inhibitors of matrix metalloproteases). Comparison of global gene expression induced by live
parasites in LEC to parasite-unexposed LEC demonstrated that filarial parasites altered the expression of those genes
involved in cellular organization and development as well as those associated with junction adherence pathways that in
turn decreased trans-endothelial transport as assessed by FITC-Dextran. The data suggest that filarial parasites directly
induce lymphangiogenesis and lymphatic differentiation and provide insight into the mechanisms underlying the
pathology seen in lymphatic filariasis.
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Introduction
Among the clinical manifestations of human infection with the
filarial nematodes Wuchereria bancrofti and Brugia malayi, the most
debilitating are those associated with lymphatic dysfunction and/
or obstruction (e.g. lymphedema, elephantiasis). It is known that
the establishment of the adult filarial parasite within the lymphatic
vessels of the host triggers a cascade of events that leads to
abnormalities in lymphatic integrity and function. In addition, the
tissue tropism of these lymphatic-dwelling parasites suggest that
the host provides cues to the parasite that provide developmental
signals to the parasites [1]. Individuals infected with the lymph-
dwelling filariae can develop tissue scarring and fibrosis within and
around the lymphatic vessels resulting in permanent and
characteristic pathology manifested clinically by irreversible
lymphedema or elephantiasis [2,3]. An extensive body of work
supports the notion that some of the severe pathology is immune
mediated [4,5,6,7] but that lymphatic dilatation and alterations in
lymphatic flow may be parasite-derived and unrelated to the
adaptive immune response. Indeed, filaria-infected SCID mice
have been shown to exhibit lymphatic dilatation [8,9], a process
that could be reversed by removing or killing the worms [10,11].
Moreover, lymphoscintigraphy studies showed that patients with
subclinical disease have considerable structural abnormalities and
aberrant lymph flow [12,13,14], and ultrasonography has
suggested that the anatomic location of the worm nests changes
very little over time but that lymphangiectasia and dilatation are
not restricted to the anatomic location of the adult worm nests
[15,16,17]. In addition, in histologic studies of lymph nodes taken
from patients with bancroftian filariasis, there were intact adult
filarial worms with little or no associated inflammation [18,19].
Together, these observations suggest a primary role of the
parasites or parasite-encoded proteins in modulating lymphatic
integrity and function. It has been speculated that, with chronic
infection, it is the death of the adult worms (be it immune
mediated or just intrinsic worm lifespan) and the release of parasite
antigens (or Wolbachia) that induce proinflammatory responses
that render a poorly functioning (and dilated) patent lymphatic
completely obstructed [20].
Based on the available animal models, it has been assumed that
the filarial parasites promote lymphangiogenesis, a developmental
process that involves lymphatic endothelial proliferation followed
by differentiation (tube formation). In vitro studies of parasite-
endothelial interactions have been limited to those using human
umbilical vein endothelial cells (HUVEC) [21] that differ quite
extensively from lymphatic endothelial cells (LEC). In the present
study, we have examined directly the influence filarial parasites
have on LEC function and lymphangiogenesis. We demonstrate
that filarial proteins do stimulate the LEC to undergo proliferation
and differentiate into tube-like structures that involves matrix
metalloproteases and tissue inhibitors of matrix metalloproteases.
We further demonstrate that, contrary to data in murine models,
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permeable and suggest possible new mechanisms underlying
filarial-induced lymphedema.
Results
Filarial antigens induce differential proliferation of LEC
Analysis by flow cytometry and quantitative reverse transcrip-
tase real-time PCR (qRT-PCR) demonstrated that the LEC were
pure and possessed all of the characteristics of lymphatic
endothelium (Figure S1). To evaluate the effect of filarial
antigens on LEC proliferation, we stimulated LEC with stage-
specific filarial antigens and measured proliferation at 96 h. As
shown in Figure 1A, antigen derived from adult Brugia malayi
parasites (BmA) or from adult male B. malayi parasites (BmMAg)
induced proliferation of LEC with stimulation indices ranging
from 8 to 35 and did so optimally at a concentration of 10 mg/ml
(optimization data not shown). In contrast, antigens from
microfilariae (MfAg) failed to induce proliferation at levels
comparable to adult antigens. The extent of proliferation induced
by BmA or BmMAg was comparable to that induced by
recombinant soluble human vascular endothelial growth factor
(VEGF)-A at 25 ng/ml used as a positive inducer of proliferation.
To address the specificity of this observed parasite-induced
proliferation, both LEC and HUVEC, as a model representative
of blood vascular endothelial cells were stimulated with the
optimal concentrations of BmA, BmMAg, and MfAg for 96 h
Author Summary
The nematode parasites Brugia malayi and Wuchereria
bancrofti are the major organisms responsible for lym-
phatic filariasis. Lymphatic filariasis is characterized by the
dysfunction of the lymphatics that can lead to severe (and
often) irreversible lymphedema and elephantiasis. Current
advances in distinguishing blood vascular from lymphatic
endothelial cells have allowed the direct study of the
interaction between live filarial parasites and their
lymphatic niche. In the quest towards understanding
parasite-lymphatic endothelium interactions, we observed
that the filarial antigens have a specific but differential
stimulatory capacity towards the lymphatics and cause
them to differentiate into tube-like vascular networks in
vitro that resemble the formation of collateral lymphatics
in vivo. This was a lymphatic-specific phenomenon, as the
filarial parasites or antigen did not exhibit similar effects on
the human umbilical vein endothelial cells. The differen-
tiation of the lymphatic endothelial monolayers into
vascular networks was not dependent on typical markers
of lymphangiogenesis but rather involves the matrix
metalloproteases and their inhibitors that suggest lym-
phatic matrix remodeling rather than rendering of the
lymphatics hyper-permeable as has been postulated
previously.
Figure 1. Filarial antigen-induced proliferation. LEC at 5610
3 were seeded in 96-well tissue culture plates in endothelial basal media and
stimulated with optimized concentrations (10 mg/ml) of BmA, BmMAg, MfAg, and VEGF (25 ng/ml or 10ng/ml). Data are expressed as stimulation
index over the unstimulated controls for each set of cultures and the horizontal bar is the geometric mean. Panels A and B show the response of LEC
(Panel A) and HUVEC (Panel B) to the stimuli shown on the x-axis. Panels C and D show the proliferative effect on HUVEC and LEC of schistosome egg
antigen (SEA Panel C) and of schistosome adult antigen (SWAP Panel D).
doi:10.1371/journal.ppat.1000688.g001
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of proliferation quantified. As shown in Figure 1B, adult filarial
antigens failed to induce proliferation of HUVEC, in marked
contrast to the proliferation induced by these antigens in LEC.
These data suggest that the filaria-induced EC proliferation was
more specific to LEC compared to the HUVECs.
To address further the specificity of this response, non-filarial
helminth antigens were tested. Because schistosome egg antigen
(SEA) had been shown previously to induce proliferation of the
HUVEC [22,23], we examined the response of crude soluble
extracts of Schistosoma mansoni adults (SWAP) and SEA on LEC and
HUVEC proliferation. As seen, SEA induced proliferation of
HUVEC but not LEC (Figure 1C), while SWAP failed to induce
proliferation of either LEC or HUVEC (Figure 1D). Together,
our data suggest that adult filarial antigens specifically induce LEC
proliferation.
Filarial serum promotes proliferation of LEC
Having observed that filarial antigens induce LEC proliferation,
we evaluated the potential of plasma (containing circulating filarial
antigens and host angiogenic factors) to stimulate LEC prolifer-
ation. Using pooled plasma from filaria-uninfected endemic
normal (EN) individuals, microfilaria-positive (MF) individuals
with asymptomatic (or subclinical) infection, individuals with
chronic lymphatic obstruction (CP), or AB serum from uninfected
individuals (Figure 2), we were able to demonstrate that plasma
from patients with lymphatic filariasis promoted LEC proliferation
in contrast to that seen for uninfected EN plasma or control (AB)
serum. As can be seen, the MF and CP plasma exhibited a
significant increased proliferation compared with the EN plasma
(p=0.0028 and p=0.028, respectively) or the AB serum
(p=0.0048 and p=0.04, respectively). There was no difference
in the proliferative capacity between the EN plasma or the AB
serum. These data implicate filarial antigens and or soluble
angiogenic factors circulating in the serum/plasma as having the
capacity to induce LEC proliferation.
Microfilarial antigens induce tube formation by LEC in
vitro
Because patent (microfilaraemic) filarial infection has been
associated with lymphatic dilatation in both animal models and in
human infection, we examined the effect of microfilarial antigen
and live microfilariae (Mf) on LEC differentiation. When cultured
in the presence of microfilarial antigens, the LEC were found to
differentiate and form lymphatic tube-like structures when
compared with unstimulated controls. Among the antigen
preparations tested, MfAg was the most potent inducer of LEC
differentiation, a process that could be observed as early as 48 h; in
contrast, adult antigens could induce similar tube-like structures
but did so only after 96 h (Figure 3, A–D). More importantly, live
parasites (microfilariae, adult males, adult females) were also
capable of inducing LEC differentiation. Live microfilariae
(Figure 3F), compared with media controls (Figure 3E), induced
LEC to form early tube like structures by 48–72 h in culture,
whereas the adult male or female parasites induced tube formation
only after 96 h in culture and did so in a limited and less complete
fashion (Figure 3H and 3J). Increasing the number of live adult
parasites did not appear to augment LEC differentiation (data not
shown). To evaluate whether tube formation was contact
dependent or independent, LEC were cultured with the parasites
in transwell inserts. Interestingly, microfilariae co-cultured with
LEC in transwell inserts also induced tube formation (Figure 3G),
while the adult parasites in transwells did not (Figure 3I and 3K).
These data suggest that this contact-independent LEC differenti-
ation is primarily mediated by the excretory-secretory products of
the parasites and of microfilariae most prominently.
MfAg-induced tube formation is independent of
expression of known lymphangiogenic molecules
Formation of lymphatic capillaries in vivo (in animal models) has
been shown to be regulated by the expression of Prox-1 and
podoplanin, among other molecules [24]. To evaluate whether the
capillary tube formation induced by microfilariae involved
upregulation of these and other molecules known to be associated
with lymphangiogenesis, we examined the expression of CEA-
CAM-1, LYVE-1, podoplanin, PROX-1, VEGF-C, and VEGFR-
3 by qRT-PCR (Figure 4). As can be seen, MfAg did not alter
expression of any of these molecules, suggesting that microfilariae-
induced LEC differentiation is not related to expression of these
particular markers.
Gene expression analysis identifies cell-cell interaction
pathways in MfAg-induced tube formation
To assess more globally the molecules involved in LEC
differentiation induced by filarial pathogens, we carried out
microarray studies comparing unstimulated LEC and MfAg-
stimulated LEC. Notably in these analyses (Tables 1 and 2),
expression of a number of genes associated with lymphangiogen-
esis (e.g. CADM1, TBK-1, GJA4, CD36, ANGPTL4, ICAM-2,
MMP-1, CASK, TGFBI, VIP, CTGF, OLFML3, SORBS2,
GJA1, MARCKS) were found to be altered by MfAg compared
with the unstimulated control; many of these (based on pathway
analysis) were associated with network functions of cellular
development, cellular assembly and organization, hematologic
system development and function, and cancer/tumor morphology.
Furthermore, the results from these microarrays indicated that the
expression of the molecules involved in maintenance of endothelial
Figure 2. Filarial serum/plasma induced proliferation. LEC
cultured with 1% pooled plasma from different patient groups (EN,
MF, CP, AB) and proliferation measured by uptake of BrDU at 96 h. Data
are expressed as relative luminescence units (rLu) over media controls
and are expressed as the mean (+95% CI).
doi:10.1371/journal.ppat.1000688.g002
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altered upon stimulation with filarial antigens (Figure 5). In
addition, when qRT-PCR was performed independently on the
majority of the genes shown to have filarial-induced alterations in
gene expression, there was a strong relationship between the
expression levels assessed by microarray and those assessed
independently by qRT-PCR (Figure S2).
Microfilariae inhibit tissue inhibitors of matrix
metalloproteinase (TIMP)-1 and TIMP-2 expression and
increase matrix metalloprotease (MMP) activity
With the microfilaria-induced increases in gene expression
associated with pathways involved in cell-cell contact, tissue
remodeling, and angiogenesis, we next assessed the levels of the
proteins (gene products) associated with these processes. Following
stimulation of LEC with MfAg, it could be shown clearly that
TIMP-1 and TIMP-2 levels were significantly inhibited (up to
75%) (Figure 6A and 6B) compared with either BmA (TIMP-1:
P=0.01; TIMP-2: P=0.02) or BmMAg (TIMP-1: P=0.03;
TIMP-2: P=0.02) -exposed LEC. There was no significant up-
or downregulation of angiopoietin-2 (Ang-2), fibroblast growth
factor (FGF), platelet-derived growth factor (PDGF), vascular
endothelial growth factors - VEGF-A, VEGF-C, or VEGF-D by
the parasite antigens. Other growth factors such as heparin-
binding epidermal growth factor (HB-EGF), hepatocyte growth
factor (HGF), keratinocyte growth factor (KGF), and thrombo-
poietin (TPO) were barely (or not) detectable (data not shown).
As MMP are regulated by the TIMPs, we next analyzed the
parasite antigen-exposed LEC for the presence of active MMPs
(MMP-1, -2, -3, -7, -8, -9, -10, and 13). Of all the MMPs assayed,
only MMP-1 and MMP-2 were consistently altered by filarial
antigen stimulation, with MfAg preferentially inducing expression
of MMP-1. As can be seen, MfAg increased expression of MMP-1
significantly more compared with adult antigens BmA (p=0.001)
and BmMAg (p=0.001) (Figure 6C). The adult antigens induced
higher levels of MMP-2 by the LEC compared with MfAg
(p=0.05) (Figure 6D). These results suggest that MfAg-induced
Figure 3. Microscopic images of filaria-induced lymphatic tube-like structure formation. LEC were seeded in endothelial basal media
(Panels A and E) and stimulated with BmA (B), BmMAg (C), and MfAg (D), live microfilariae (F), live adult males (H), adult females (J) in contact or in
transwells with live microfilariae (G), adult males (I), or adult females (K). (Magnification 206(Panels A–D), 406(Panels E–K)).
doi:10.1371/journal.ppat.1000688.g003
Figure 4. Expression of lymphangiogenic markers upon
stimulation with MfAg by LEC as assessed by qRT-PCR. Data
are expressed as the mean (+95% CI) fold change from unstimulated
controls of 4 independent experiments.
doi:10.1371/journal.ppat.1000688.g004
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Name Description Fold Change
CADM1 cell adhesion molecule 1 12.295
TBK1 TANK-binding kinase 1 8.664
RBP7 retinol binding protein 7, cellular 7.346
GJA4 gap junction protein, alpha 4, 37kDa 7.341
ADFP adipose differentiation-related protein 7.321
CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1 6.788
PLTP phospholipid transfer protein 6.727
CASK calcium/calmodulin-dependent serine protein kinase (MAGUK family) 6.476
ANGPTL4 angiopoietin-like 4 6.422
CD36 CD36 molecule (thrombospondin receptor) 6.16
TGFBI transforming growth factor, beta-induced, 68kDa 5.93
ENC1 ectodermal-neural cortex (with BTB-like domain) 5.844
ACSL1 acyl-CoA synthetase long-chain family member 1 5.641
C19ORF2 chromosome 19 open reading frame 2 5.468
GUSB glucuronidase, beta 4.897
IQGAP2 IQ motif containing GTPase activating protein 2 4.857
FAM14A family with sequence similarity 14, member A 4.646
GUCY1A3 guanylate cyclase 1, soluble, alpha 3 4.643
MMP1 matrix metallopeptidase 1 (interstitial collagenase) 4.624
HDAC5 histone deacetylase 5 4.563
KIF21A kinesin family member 21A 4.547
RPESP RPE-spondin 4.525
SYT9 synaptotagmin IX 4.359
IL1R1 interleukin 1 receptor, type I 4.332
PDK4 pyruvate dehydrogenase kinase, isozyme 4 4.305
NP nucleoside phosphorylase 4.305
NNMT nicotinamide N-methyltransferase 4.263
GADD45G growth arrest and DNA-damage-inducible, gamma 4.26
FAM46A family with sequence similarity 46, member A 4.249
CREB5 cAMP responsive element binding protein 5 4.216
UCHL1 ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) 4.158
CH25H cholesterol 25-hydroxylase 4.05
6-Sep septin 6 4.045
VIP vasoactive intestinal peptide 4.008
ATP5G2 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C2 (subunit 9) 3.994
CECR1 cat eye syndrome chromosome region, candidate 1 3.992
CIB1 calcium and integrin binding 1 (calmyrin) 3.853
ICAM2 intercellular adhesion molecule 2 3.818
RPS9 ribosomal protein S9 3.816
AKR1C2 aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid
binding protein; 3-alpha hydroxysteroid dehydrogenase, type III)
3.813
BCL11A B-cell CLL/lymphoma 11A (zinc finger protein) 3.766
PLA2R1 phospholipase A2 receptor 1, 180kDa 3.735
CLDN23 claudin 23 3.727
PRELID1 PRELI domain containing 1 3.678
FECH ferrochelatase (protoporphyria) 3.671
OAS1 29,59-oligoadenylate synthetase 1, 40/46kDa 3.671
MYL6B myosin, light chain 6B, alkali, smooth muscle and non-muscle 3.638
GDF15 growth differentiation factor 15 3.638
FLOT1 flotillin 1 3.63
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and inhibition of TIMP-1 and TIMP-2.
Filarial antigens do not induce permeability of LEC
Lymphedema in filaria-infected individuals is assumed to result
from the lymphatic endothelium being rendered hyperpermeable,
but the results from the microarrays (Tables 1 and 2 and
Figure 5) suggest an increase in the cell-cell junction genes coding
for the proteins that would actually limit trans-endothelial
transport. Nevertheless, we evaluated the antigen-induced perme-
ability of LEC in vitro. As shown (Figure 7), monolayers of LEC
exposed to BmA or MfAg for 16–20h had permeability
measurements similar to those of unstimulated controls, whereas
known inducers of permeability (e.g., TNF-a, IL-1a) were capable
of inducing significant trans-endothelial permeability. These data
suggest that the changes induced by filarial antigens do not
increase trans-endothelial passage of small molecules. In addition,
BmA or MfAg were able to impede the permeability effect of
TNF-a and IL-1a.
Discussion
The pathologic hallmark of lymphatic filariasis is lymphedema
and elephantiasis that has been associated with lymphatic
dilatation, tortuosity, and obstruction. It is known, however, that
individuals carrying adult worms (with or without microfilaremia)
may have lymphangiectasia, acute lymphangitis, and lymphedema
of the extremities [17]. Further, it has been postulated that with
sufficient infection chronicity, individuals who harbor adult
Wuchereria bancrofti will develop lymphangiectasia in the vicinity
of the worm nests [20]. Although it is not clear what induces the
lymphatic dysfunction in filaria-infected individuals, previous
studies have shown that filarial antigens do not induce prolifer-
ation of HUVEC in vitro and, in fact, inhibited their proliferation
[21]. More recent findings, implicate the role of VEGF family
members in filarial pathology [25,26,27,28]. The availability of
markers (Prox-1, podoplanin, LYVE-1, VEGFR-3, among others)
to differentiate LEC from blood vascular endothelial cells has
facilitated the study of LEC directly. Although LEC have a lower
turnover rate compared with blood vascular endothelial cells, on
appropriate stimulation in vivo, LEC are capable of proliferating
and migrating to organize into new lymphatic vessels (lymphan-
giogenesis) [29]. That this process occurs in response to filarial
infection/antigens is demonstrated by our findings that filarial
antigens specifically induce LEC proliferation and/or differenti-
ation and do so in an antigen-specific manner. Compared to the
LECs, under identical serum deprived conditions, VEGF-A
induced proliferation of the HUVEC was similar to that of filarial
antigens. It is not clear if the observed lower proliferative response
of the HUVECs (compared to the LEC) to both the filarial
antigens and VEGF-A reflects on their maximum proliferative
capacity in vitro. Further, the failure of the filarial antigens to
stimulate both the LECs and HUVECs in the presence of serum
supplemented media compared to unstimulated controls probably
reflects on various growth factors in the sera masking the
proliferative capacity of the antigens, which could possibly account
for similar observation with HUVECs previously [21]. Though
VEGF-C (native or the mutant form of VEGFC-156Ser)
specifically activates LEC, it was unable to induce significant
proliferation of the LEC at the concentration similar to VEGF-A
Name Description Fold Change
ACADVL acyl-Coenzyme A dehydrogenase, very long chain 3.613
ZNF197 zinc finger protein 197 3.573
RPL18A ribosomal protein L18a 3.497
KIAA1271 virus-induced signaling adapter 3.492
ATP8A1 ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 3.482
TSKU tsukushin 3.463
HMOX1 heme oxygenase (decycling) 1 3.449
ID4 inhibitor of DNA binding 4, dominant negative helix-loop-helix protein 3.378
ALDH2 aldehyde dehydrogenase 2 family (mitochondrial) 3.359
MCTS1(includesEG:28985) malignant T cell amplified sequence 1 3.338
HERC5 hect domain and RLD 5 3.26
SPTBN1 spectrin, beta, non-erythrocytic 1 3.211
CHST3 carbohydrate (chondroitin 6) sulfotransferase 3 3.134
INHBB inhibin, beta B 3.125
DYRK2 dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 3.108
PAG1 phosphoprotein associated with glycosphingolipid microdomains 1 2.988
MGC11324 lung cancer metastasis-associated protein 2.961
MGMT O-6-methylguanine-DNA methyltransferase 2.946
RHOU ras homolog gene family, member U 2.944
MGLL monoglyceride lipase 2.944
DCLRE1C DNA cross-link repair 1C (PSO2 homolog, S. cerevisiae) 2.912
NOC2L nucleolar complex associated 2 homolog (S. cerevisiae) 2.902
doi:10.1371/journal.ppat.1000688.t001
Table 1. Cont.
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Name Description Fold Change
CTGF connective tissue growth factor 8.586
ACTB actin, beta 8.129
OLFML3 olfactomedin-like 3 6.238
SORBS2 sorbin and SH3 domain containing 2 5.134
PEG10 paternally expressed 10 4.721
IER3 immediate early response 3 4.287
RRM2 ribonucleotide reductase M2 polypeptide 4.095
GJA1 gap junction protein, alpha 1, 43kDa 4.093
RPL24 ribosomal protein L24 4.056
MARCKS myristoylated alanine-rich protein kinase C substrate 3.983
SNCAIP (includes EG:9627) synuclein, alpha interacting protein (synphilin) 3.784
GFRA1 GDNF family receptor alpha 1 3.663
SC4MOL sterol-C4-methyl oxidase-like 3.338
DHCR24 24-dehydrocholesterol reductase 3.31
DDAH1 dimethylarginine dimethylaminohydrolase 1 3.297
ERBB4 v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) 3.285
SEMA3C sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C 3.236
GCNT1 glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase) 3.224
USP21 ubiquitin specific peptidase 21 3.123
NEBL nebulette 3.055
PLA2G4B phospholipase A2, group IVB (cytosolic) 2.979
EPS15L1 epidermal growth factor receptor pathway substrate 15-like 1 2.86
NAPE-PLD N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D 2.678
CASP4 caspase 4, apoptosis-related cysteine peptidase 2.519
doi:10.1371/journal.ppat.1000688.t002
Figure 5. Expression of junction molecules by LEC by microarray analysis. Shown in the heat map are the relative expression levels of the
genes listed in response to BmA (B) or MfAg (M) at 24-, 48-, and 72-h time points. The control values (C) are the relative expression levels of pooled
controls at the time-points listed. The heat map scale is shown in the inset.
doi:10.1371/journal.ppat.1000688.g005
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PLoS Pathogens | www.plospathogens.org 7 December 2009 | Volume 5 | Issue 12 | e1000688Figure 6. Filarial antigens induce metalloproteases MMP-1 and MMP-2. Shown are the levels of TIMP-1 (Panel A) and TIMP-2 (Panel B), MMP-
1 (Panel C) and MMP-2 (Panel D) upon stimulation with various filarial antigens. Data are expressed as the mean (+95% CI) % change from control
(media) for 3 independent experiments.
doi:10.1371/journal.ppat.1000688.g006
Figure 7. BmA and MfAg inhibit the TNF-a or IL-1a induced hyper-permeability of LEC monolayers. Shown are the mean (+95% CI)
relative fluorescence units of 4 independent permeability assays through LEC confluent monolayers.
doi:10.1371/journal.ppat.1000688.g007
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(SEA or SWAP) that have no effect on LEC (present study) but do
induce the proliferation of HUVECS (Figure 1C, 1D) [22], both
adult filarial antigens and serum from patients with lymphatic
filariasis induce LEC proliferation. As has been shown by others
[25,26,27,28], it is possible that circulating levels of pro-
lymphangiogenic factors or circulating parasite antigens
(.32,000 Og4C3 units in plasma of infected individuals, data
not shown) themselves could be stimulating LECs in vivo.I n
addition, MfAg appears to induce lymphatic vessel differentiation
and remodeling that may be aided by the alteration of the
extracellular matrix.
The lymphangiogenic response requires both upregulation of
lymphangiogenic factor expression and downregulation of the
inhibitors of lymphangiogenesis [30] (typically involved in degra-
dation and synthesis of the extracellular matrix components
[31,32]). Although VEGF family members have been considered
the prime mediators of lymphangiogenesis, many other mediators
have been identified that can also influence the lymphatic
vasculature [33,34,35,36,37]. Among these HGF, bFGF, PDGF,
angiopoeitins, and IGF-1 are known inducers and/or regulators of
lymphangiogenesis; however, we were unable to detect any
significant increase in the levels of HGF, b-FGF, ANG-2 or PDGF
in the culture supernatants of LEC stimulated with MfAg. This
however does not preclude the release of VEGF in in vivo conditions
by the immune cells such as the macrophages that could aid in the
filarial pathology. Thus, the host factors mediating lymphangiogen-
esis and lymphatic differentiation awaits clarification.
Typically, confluent monolayers of lymphatic endothelium in
the presence of growth factors form tubular networks that are
similar in their structural arrangement to lymphatic capillaries in
vivo [38]. EM analysis of these tubular structures suggested that the
flattened EC form a luminal space comprising one to several EC.
Typical studies on lymphangiogenesis utilize collagen- or gelatin-
coated culture plates or, for 3-dimensional studies, Matrigel
TM;
however, filarial antigen-induced tube formation did not require
any pre-existing matrix, suggesting that laminin and collagen type
IV (major components of Matrigel
TM) are not absolutely essential
for differentiation of LEC in vitro as has been demonstrated in
previous in vitro studies [39,40]. This is indicative of the capillary
EC inherent capacity to produce and secrete factors that can aid in
tissue remodeling (e.g. MMP) [41]. The activity of MMP is further
controlled by endogenous TIMP that can bind to zymogens or
inhibit the activated forms of MMP [42,43,44,45]. TIMP-1 and
TIMP-2 are the best-known inhibitors that can suppress capillary
endothelial cell function in vitro. The filarial antigen-induced tube
formation seen in the present study seemed most dependent on
regulation of TIMP-1 and TIMP-2 that were, in turn, associated
with increased levels of MMP-1 and MMP-2. Preliminary data
suggest that addition of exogenous TIMP-1 and TIMP-2 inhibit
the antigen-induced tube formation to a considerable extent (data
not shown). It remains to be seen how TIMP and MMP regulate
LEC activity upon stimulation with filarial antigens, although their
role in development of collateral/accessory lymphatics in cats
infected with Brugia pahangi [46] and in humans with lymphatic
filariasis has been postulated previously.
A characteristic feature of long-term filarial infection in humans
and animals is the fibrosis and cellular hyperplasia in and around the
lymphatic walls. Infection with the parasites for long periods results in
the fibrosis of the infected lymph nodes, which eventually become
non-functional and are bypassed by new lymphatic vessels [46].
Several animal studies [47,48,49] have previously shown that EC
from infected animals had a decreased number of vesicles (which
presumably transport fluid)and anincrease in the number ofvacuoles
(which presumably results from cell damage), suggesting that EC
lining the lymphatics inhabited by the filarial worms are affected by
the parasites. The injury probably renders these EC less effective in
transporting edematous fluid and thereby contributes to the edema
and collagen accumulation. Studies on LEC permeability (as an
indirect measure of their transport capability) demonstrated that,
upon stimulation with filarial antigens, LEC are not rendered
hyperpermeable but rather are made less leaky, in large part by the
induction of adhesion molecules involved in maintaining cell
junctions. A recent study using Dirofilaria immitis antigen on EC also
suggests that antigen-treated monolayers do not differ from the
unstimulated controls in the trans-endothelial passage of FITC-
Dextran [50]. These data suggest that the lymphedema associated
with filarial infection is associated with an inability of the parasite-
exposed lymphatics to resorb interstitial fluid rather than for fluid to
pass through the LEC junctions abnormally. Alternatively, the
proinflammatory responses (IL-1, TNF-a) seen in immune effector
cells from patients with chronic lymphatic obstruction [51] could
themselves render the LEC hyperpermeable. The proliferative effects
of the adult antigens and more pronounced tube-formation activity of
the microfilarial antigens, perhaps is an indication of the lymphatic
dilatation/damage seen in the sub-clinical infections. It is not
absolutely clear, but the consensus on the progression and
development of lymphedema/elephantiasis lies in the death of the
parasites that triggers a massive inflammatory response against the
parasite products and its endosymbiont wolbachia. By whatever
mechanism, the interstitial fluid remains and leads to fibrosis and
tissue injury.
Thus, our studies reveal that filarial parasites are capable of
inducing lymphangiogenesis in vitro, a process that is LEC specific
and relates to the excretory-secretory components of the filarial
parasites and/or the elevated levels of circulating lymphangiogenic
factors [26]. The new vessels formed appear to be associated with
intrinsic extracellular matrix modeling and are not related to
expression of prototypical markers of lymphangiogenesis seen in
tumor biology. Our data also suggest that filarial lymphedema
may not be due to parasite-induced alterations in trans-endothelial
transport (as has been hypothesized) but may involve host-
expressed inflammatory components. With the elucidation of the
stage-specific excretory-secretory components of B. malayi [52,53],
further studies on the effects of these ES products (and their
purified components) on the LECs would enable a clearer
understanding of the filarial induced lymphatic dysfunction
associated with lymphatic filariasis.
Materials and Methods
Cell cultures
Human dermal microvascular endothelial cells (HDMEC),
human lymphatic microvascular endothelial cells (here called
LEC), and human umbilical vein endothelial cells (HUVEC) were
obtained from Cambrex. LEC and HUVEC (together referred to
as EC) were cultured in EGM-2MV (Cambrex), serially
subcultured, and maintained through 7–8 passages in T75 tissue
culture flasks (Sarstedt; Fisher Scientific). All experiments were
performed using cells from passages 3–5. The purity of LEC was
verified by their cell surface expression of podoplanin, VEGFR-3,
and LYVE-1 by flow cytometry and confocal microscopy.
Measurement of LEC marker expression by flow
cytometry, confocal microscopy and quantitative reverse
transcriptase real-time PCR (qRT-PCR)
For flow cytometry analyses, the cells were detached from the
culture flasks by trypsinization per manufacturer’s instructions
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(for flow cytometry) or adherent cells in 8-well chambered glass
slides (Lab-Tek; NUNC) (for confocal microscopy) were stained
individually or in combination with mouse monoclonal anti-
human LYVE-1 (MAB2089; R&D Systems), anti-human ICAM-
1-FITC (BBA20; R&D Systems), anti-human VEGFR3-APC
(FAB3492A; R&D Systems), mouse anti-human CD44-PE (BD
Pharmingen), or mouse polyclonal anti-human podoplanin (Cell
Sciences). Anti-mouse IgG coupled with Alexa Fluor 594 or Alexa
Fluor 488 were from BD Pharmingen. Staining with isotype
control Ab were performed in parallel. Flow cytometry data were
analyzed by FlowJo (Treestar Inc.). Confocal microscopy was
carried out using a Leica-SP2-AOBS unit at the NIAID Biologic
Imaging Facility.
QRT-PCR was performed on total RNA samples using commer-
cially available assays (TaqMan
TM; Applied Biosystems) for podopla-
nin, LYVE-1, Prox-1, VEGF-C, VEGFR-3, MRC-2, CEACAM, and
CD44 on an ABI Prism 7900 sequence detection system (Applied
Biosystems). All data are initially expressed as fold change from the
endogenous control (18s rRNA). Details of the genes targeted for
assessment of quantitative RT-PCR are listed in Table S1.
Antigens, adult parasites, and microfilariae
Soluble extracts of B. malayi adult parasites (BmA), adult male
(BmMAg), and microfilariae (MfAg) were prepared as described
previously [54], as were soluble extracts of Schistosoma mansoni
(SWAP) and egg antigen (SEA) [22]. B. malayi antigens were used
both because of their ability to be maintained in animal hosts and
because of their extensive homology to the other lymphatic
dwelling filariae, W.bancrofti that has as its only host, humans.
Live adult parasites and microfilariae were obtained from the
NIH/NIAID-Filariasis Research Reagent Repository Center at
the University of Georgia, Athens. The animal procedures were
conducted in accordance with ACUC guidelines with the approval
from the Institutional Review Boards at the National Institutes of
Health and at the University of Georgia. The adult worms were
washed thoroughly in RPMI-1640 supplemented with penicillin/
streptomycin, 2 mM L-glutamine, and 10 g/l of d-glucose (MF-
media). Microfilariae were washed and resuspended in MF-media,
layered onto LSM (MP Biomedicals), and centrifuged at 1750 rpm
for 20 min. The pellet of live microfilariae was cleared of all
contaminating cells by incubation with lysis buffer for 10 min,
washed in MF-media, and enumerated.
Proliferation of LEC and HUVEC
Primary EC were detached from culture flasks by trypsinization
and seeded at a density of 5610
3 cells/well in 96-well flat-
bottomed plates in EGM-2MV media (Cambrex). The cells were
starved overnight in endothelial basal media (EBM-2) before being
stimulated with various concentrations of BmA, BmMAg, or
MfAg. SWAP and SEA were used as nonspecific parasite stimulus.
VEGF-A and VEGF-C were used as specific stimulators of EC.
Untreated cells with media alone served as negative controls. EC
were cultured at 37uC for 96 h in a 5% CO2 incubator in EBM-2
media with/without any growth factors. The cells were pulsed
with 1 mCi of H
3-thymidine 16 h prior to harvesting. The cells
were harvested at 96 h and the amount of incorporated H
3-
thymidine measured by Wallac scintillation counter (Perkin
Elmer).
Proliferation of LEC in the presence of 0.5% to 1% previously
well characterized serum from endemic normals (EN), asymptom-
atic microfilaraemic (MF), and chronic pathology (CP), or control
AB was assayed by incorporation of BrDU (Invitrogen) as per the
manufacturer’s instructions.
In vitro tube formation assays
LEC were seeded at a density of 0.5610
6 cells in 6-well plates
(Costar; Fisher Scientific) in EGM-2MV media. The cells were
starved overnight in EBM-2 media and were stimulated with
antigen preparations (BmA, BmMAg, and MfAg) or live parasites.
The live adult parasites (3–4 adults/well) or live microfilariae
(50,000) were co-cultured with LEC directly or in transwells. Tube
formation was observed and imaged using a Zeiss confocal
microscope under a PlastDIC lens every 24 h.
Angiogenic factors
The culture supernatants from LEC stimulated with filarial
antigens or live parasites after 24, 48, 72, and 96 h were
screened for Ang-2, FGF-b, HB-EGF, HGF, KGF, PDGF-BB,
TIMP-1, TIMP-2, VEGF, VEGF-C, VEGF-D, TPO, or MMP-
1, -2, -3, -7, -8, -9, -10, and -13 by multiplex arrays (Searchlight).
The intra- and inter-assay coefficients of variances for the
multiplexed array were observed to be less than 10% and 25%
respectively.
Permeability assays
Permeability assays on LEC were carried out as the manufac-
turer’s instructions using the in vitro vascular permeability assay kit
(Chemicon Intl.). Briefly, LEC were seeded at a density of 2610
5
cells on collagen-coated transwell inserts in a 24-well tissue culture
plate. The cells were cultured for 48 h in EGM-2MV medium for
confluent monolayers. The cells in the monolayers were starved
overnight with EBM-2 basal medium, the media was replaced,
and cells were stimulated with antigens for 16–20 h. Permeability
was measured based on the amount of FITC-dextran that diffused
from the transwell into the lower compartment.
Microarray analysis
Equal quantities of total RNA from LEC and LEC exposed to
MfAg or BmA were converted to aminoallyl-labeled cDNA using
the Ovation aminoallyl amplification and labeling system per the
manufacturer’s instructions (NuGEN Technologies, Inc.). The
aminoallyl-labeled cDNA were labeled using Amersham CyDye
(Cy3, unstimulated controls; Cy5, stimulated) reactive post-dye
protocol (GE Healthcare) and hybridized onto custom microarrays
manufactured by the Microarray Research Facility of the NIAID.
The human microarray (Hsbb) probe set is based on 70mer
oligonucleotides from Qiagen’s Human Genome Oligo Set V2.0.
A comprehensive gene list is available at http://madb.niaid.nih.
gov/cgi-bin/gipo.
Images of the scanned arrays were analyzed, and data were
filtered using the criteria of fold-change of $2 (upregulation) or
#2 (downregulation) of the genes compared with unstimulated
controls. For categorizing and pathway analysis, ingenuity
pathway analysis (IPA, www.ingenuity.com) was used. Selected
genes involved in cell-cell junctions were analyzed by qRT-PCR.
The details of the primer/probe sets used are listed in Table S1.
The microarray data are available at the NCBI GEOS website
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE15454.
Statistical analysis
Data analyses were performed using GraphPad PRISM
(GraphPad Software, Inc., San Diego, CA). Unless otherwise noted,
geometric means (GM) were used for measurements of central
tendency. Statistically significant differences between two groups
were analyzed using the non-parametric Mann-Whitney U test.
Correlations were calculated by Spearman Rank correlation test.
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Figure S1 Characterization of LEC. LEC were analyzed for
expression of lymphatic specific markers (A) podoplanin, (B)
VEGFR3, (C) LYVE 1 and for absence of BEC markers (D) CD44
and (E) ICAM. LEC were .98% podoplanin positive and
negative for CD44 and ICAM (F and G). The isotype controls
are solid peaks (A E). (H-K) Confocal images of LEC showing
podoplanin (Alexa Fluor 488) (H), LYVE 1 (Alexa Fluor 594) (I),
co localization of podoplanin and LYVE 1 (J), and DIC image of
the LEC (K). (L) QRT-PCR expression of LEC specific markers as
fold change compared with HDMEC.
Found at: doi:10.1371/journal.ppat.1000688.s001 (0.56 MB PDF)
Figure S2 Quantitative reverse transcriptase real-time PCR data
correlates strongly with expression levels assessed by microarray.
Shown is the relationship of individual gene expression (fold
change over media) as assessed by microarray (y-axis) and qRT-
PCR in response to BmA at 24hrs (A), MfAg at 24hrs (B) BmA at
72 hours (C) and MfAg at 72 hours (D).
Found at: doi:10.1371/journal.ppat.1000688.s002 (0.05 MB PDF)
Table S1 List of genes targeted for qRT-PCR used to evaluate
gene expression.
Found at: doi:10.1371/journal.ppat.1000688.s003 (0.05 MB
DOC)
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